参考来源: US FDA approves expanded age indication for GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk. News release. GSK. June 7, 2024. Accessed June 10, 2024. 注:...
Oct. 18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV) now have a new set of data to help them make up their minds. A large study inThe Lancetconcluded the vaccine is 80% effective at preventing hospitalization due to complic...
Earlier this year, the US Food and Drug Administration (FDA) approved the first respiratory syncytial virus (RSV) vaccines in the United States for older adults. Adults aged 60 years or older may get an RSV vaccine after discussion with their healthcare provider according to recommendations from ...
Promising Top-Line Results for RSV Vaccine in Immunocompromised Adults Samantha Anderer JAMA. 2024;332(13):1043. doi:10.1001/jama.2024.17607 Full Text Pfizer’s ABRYSVO vaccine was safe and generated a strong immune response against respiratory syncytial virus (RSV) in immunocompromised adults aged...
Older adults aren't the only group impacted by RSV. Very young children have been at the center of this winter's unusually severe RSV surge, which is now seeingcasesclimbing down from a steep peak. Pfizer also has amaternal vaccinein the race, which would be given to parents-to-be in ...
参考来源:‘US FDA approves Pfizer’s RSV vaccine Abrysvo for adults aged 18 to 59 at increased risk for disease. News release. Pfizer. October 22, 2024. Accessed October 23, 2024.’ 注:本文旨在介绍医药健康研究,不作任何用药依据,具体用药指引,请咨询主治医师。
The vaccines can be co-administered with COVID-19 and influenza vaccines in older adults, and the Abrysvo vaccine can be administered to pregnant women between 24 and 36 weeks gestation. However, the vaccines are not yet available on the National Immunisation Program...
The US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any mRNA shot has been authorized against a disease other than COVID-19.
GSK's vaccine will next need to be recommended for adults between 50 and 59 years old by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices. Their backing, at upcomingmeetingsin June or October, would tee up insurance coverage. ...
RSV vaccines are available. Three RSV vaccines have been approved for older adults by the U.S. Food and Drug Administration. You only need a single dose that you can get at any time of the year, but getting the vaccine in the early fall offers the best protection for the late fall and...